双酚A作为促进非酒精性脂肪性肝病的环境因素的作用:体外与临床研究
纳入60例经组织学诊断的非酒精性脂肪性肝病(NAFLD)患者与60名健康对照,比较血浆和尿液双酚A水平,并在HepG2细胞中评估双酚A对氧化应激与增殖的影响。NAFLD患者双酚A水平显著高于对照,非酒精性脂肪性肝炎患者高于单纯性脂肪变者,无麸质饮食1个月后循环水平下降。
要点
- NAFLD患者血浆和尿液双酚A水平均显著高于健康对照(P < 0.0001)。
- 非酒精性脂肪性肝炎患者双酚A水平高于单纯性脂肪变者(P < 0.05),与2型糖尿病无关。
- 无麸质饮食1个月后NAFLD患者循环双酚A水平显著下降(P < 0.05),尿液水平无显著下降。
核心结论
- 研究提示双酚A可能是参与促进NAFLD的环境因素,尤其在2型糖尿病患者中。
研究设计与样本
- 纳入60例经组织学诊断的NAFLD患者(伴或不伴2型糖尿病)和60名健康对照,检测血浆和尿液双酚A水平。
- 体外使用人HepG2细胞,在高糖(H-HepG2)和低糖(L-HepG2)条件下暴露于0.025和0.05 μM双酚A 48小时,评估增殖和脂质过氧化。
主要发现
- 60例NAFLD患者血浆和尿液双酚A水平均显著高于对照(P < 0.0001)。
- 30例非酒精性脂肪性肝炎患者双酚A水平高于30例单纯性脂肪变者(P < 0.05),与2型糖尿病无关。
- 无麸质饮食1个月后,NAFLD患者循环双酚A水平显著下降(P < 0.05),尿液水平无显著下降。
- 高糖HepG2细胞暴露于0.05 μM双酚A 48小时后增殖较对照增加(P < 0.0001)。
- 双酚A暴露48小时后TBARS水平较对照升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bisphenol A is an endocrine disrupting chemical associated with type 2 diabetes mellitus (T2DM), cardiovascular disease and liver enzyme abnormalities. AIM: To evaluate bisphenol A plasma and urine levels in non-alcoholic fatty liver disease (NAFLD) patients compared to healthy subjects. Furthermore, we evaluated, in human HepG2 cells, the effects of exposure to different concentrations of bisphenol A on both oxidative stress induction and cell proliferation. METHODS: We enrolled 60 patients with histological diagnosis of NAFLD with or without T2DM and sixty healthy subjects. In vitro, the proliferation of bisphenol A-exposed HepG2 cells at two different concentrations (0.025 and 0.05 μM) was evaluated, both at high (H-HepG2) and at low (L-HepG2) glucose concentrations for 48 h. Lipoperoxidation was assessed by thiobarbituric acid reactive substances (TBARS) assay. RESULTS: Bisphenol A levels were significantly higher in 60 NAFLD subjects, both in urine and in plasma (P < 0.0001) when compared to controls and, in this group, it appeared to be higher in 30 non-alcoholic steatohepatitis patients compared to 30 simple steatosis subjects (P < 0.05), independently from the presence of T2DM. After a bisphenol A-free diet for 1 month, NAFLD patients showed a significant reduction in bisphenol A circulating levels (P < 0.05), without a significant reduction in urine levels. H-HepG2 cells treated with bisphenol A (0.05 μM) increased proliferation compared to controls at 48 h (P < 0.0001). Bisphenol A increased TBARS levels at 48 h versus controls. CONCLUSIONS: Our study reveals a possible role of bisphenol A as an environmental factor involved in the promotion of NAFLD, particularly in T2DM patients.
引用
- Dallio M, Masarone M, Errico S, et al. Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: in vitro and clinical study. Aliment Pharmacol Ther. 2018. PMID: 29322544. doi:10.1111/apt.14499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。